🎉 M&A multiples are live!
Check it out!

Carl Zeiss Meditec Valuation Multiples

Discover revenue and EBITDA valuation multiples for Carl Zeiss Meditec and other public comps.

See Carl Zeiss Meditec Valuation Multiples

Carl Zeiss Meditec Overview

About Carl Zeiss Meditec

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.


Founded

1977

HQ

Germany
Employees

4.8K+

Website

zeiss.com

Financials

LTM Revenue $2.2B

LTM EBITDA $378M

EV

$5.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Carl Zeiss Meditec Financials

Carl Zeiss Meditec has a last 12-month revenue of $2.2B and a last 12-month EBITDA of $378M.

In the most recent fiscal year, Carl Zeiss Meditec achieved revenue of $2.2B and an EBITDA of $420M.

Carl Zeiss Meditec expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Carl Zeiss Meditec valuation multiples based on analyst estimates

Carl Zeiss Meditec P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $2.0B $2.2B $2.2B $2.2B XXX
Gross Profit $1.2B $1.3B $1.1B XXX XXX
Gross Margin 59% 58% 53% XXX XXX
EBITDA $503M $523M $420M $378M XXX
EBITDA Margin 25% 24% 20% 17% XXX
Net Profit $306M $303M $186M XXX XXX
Net Margin 15% 14% 9% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Carl Zeiss Meditec Stock Performance

As of February 7, 2025, Carl Zeiss Meditec's stock price is EUR 58 (or $61).

Carl Zeiss Meditec has current market cap of EUR 5.1B (or $5.3B), and EV of EUR 5.2B (or $5.4B).

See Carl Zeiss Meditec trading valuation data

Carl Zeiss Meditec Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$5.4B $5.3B XXX XXX XXX XXX $2.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Carl Zeiss Meditec Valuation Multiples

As of February 7, 2025, Carl Zeiss Meditec has market cap of $5.3B and EV of $5.4B.

Carl Zeiss Meditec's trades at 2.5x LTM EV/Revenue multiple, and 14.4x LTM EBITDA.

Analysts estimate Carl Zeiss Meditec's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Carl Zeiss Meditec and 10K+ public comps

Carl Zeiss Meditec Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $5.4B XXX XXX XXX
EV/Revenue 2.5x XXX XXX XXX
EV/EBITDA 13.0x XXX XXX XXX
P/E 29.0x XXX XXX XXX
P/E/Growth 2.4x XXX XXX XXX
EV/FCF 45.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Carl Zeiss Meditec Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Carl Zeiss Meditec Valuation Multiples

Carl Zeiss Meditec's NTM/LTM revenue growth is 7%

Carl Zeiss Meditec's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Carl Zeiss Meditec's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Carl Zeiss Meditec's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Carl Zeiss Meditec and other 10K+ public comps

Carl Zeiss Meditec Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -1% XXX XXX XXX XXX
EBITDA Margin 19% XXX XXX XXX XXX
EBITDA Growth -20% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 26% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 22% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue 17% XXX XXX XXX XXX
Opex to Revenue 44% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Carl Zeiss Meditec Public Comps

See valuation multiples for Carl Zeiss Meditec public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
Electromed XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Carl Zeiss Meditec M&A and Investment Activity

Carl Zeiss Meditec acquired  XXX companies to date.

Last acquisition by Carl Zeiss Meditec was  XXXXXXXX, XXXXX XXXXX XXXXXX . Carl Zeiss Meditec acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Carl Zeiss Meditec

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Carl Zeiss Meditec

When was Carl Zeiss Meditec founded? Carl Zeiss Meditec was founded in 1977.
Where is Carl Zeiss Meditec headquartered? Carl Zeiss Meditec is headquartered in Germany.
How many employees does Carl Zeiss Meditec have? As of today, Carl Zeiss Meditec has 4.8K+ employees.
Is Carl Zeiss Meditec publicy listed? Yes, Carl Zeiss Meditec is a public company listed on ETR.
What is the stock symbol of Carl Zeiss Meditec? Carl Zeiss Meditec trades under AFX ticker.
When did Carl Zeiss Meditec go public? Carl Zeiss Meditec went public in 2000.
Who are competitors of Carl Zeiss Meditec? Similar companies to Carl Zeiss Meditec include e.g. Philips, Perspective Therapeutics, Electromed, InfuSystem.
What is the current market cap of Carl Zeiss Meditec? Carl Zeiss Meditec's current market cap is $5.3B
What is the current revenue of Carl Zeiss Meditec? Carl Zeiss Meditec's last 12-month revenue is $2.2B.
What is the current EBITDA of Carl Zeiss Meditec? Carl Zeiss Meditec's last 12-month EBITDA is $378M.
What is the current EV/Revenue multiple of Carl Zeiss Meditec? Current revenue multiple of Carl Zeiss Meditec is 2.5x.
What is the current EV/EBITDA multiple of Carl Zeiss Meditec? Current EBITDA multiple of Carl Zeiss Meditec is 14.4x.
What is the current revenue growth of Carl Zeiss Meditec? Carl Zeiss Meditec revenue growth between 2023 and 2024 was -1%.
Is Carl Zeiss Meditec profitable? Yes, Carl Zeiss Meditec is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.